{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:35Z","timestamp":1762866155203,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.clml.2013.02.015","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:19:08Z","timestamp":1362788348000},"page":"198-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genomic Abnormalities of Waldenstr\u00f6m Macroglobulinemia and Related Low-Grade B-Cell Lymphomas"],"prefix":"10.1016","volume":"13","author":[{"given":"Esteban","family":"Braggio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2013.02.015_bib1","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1158\/0008-5472.CAN-08-3701","article-title":"Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia","volume":"69","author":"Braggio","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2013.02.015_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3816\/CLM.2009.n.009","article-title":"High-resolution genomic analysis in Waldenstr\u00f6m's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas","volume":"9","author":"Braggio","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.clml.2013.02.015_bib3","article-title":"Cytogenetic abnormalities in a cohort of 171 patients with Waldenstr\u00f6m macroglobulinemia before treatment: clinical and biological correlations","volume":"116","author":"Nguyen-Khac","year":"2010","journal-title":"Blood (ASH annual meeting abstracts)"},{"key":"10.1016\/j.clml.2013.02.015_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-4608(01)00526-X","article-title":"Deletions of 17p13.1 and 13q14 are uncommon in Waldenstr\u00f6m macroglobulinemia clonal cells and mostly seen at the time of disease progression","volume":"132","author":"Schop","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2013.02.015_bib5","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood.V100.8.2996","article-title":"Waldenstr\u00f6m macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions","volume":"100","author":"Schop","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2013.02.015_bib6","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.leu.2404314","article-title":"Trisomy 4, a new chromosomal abnormality in Waldenstr\u00f6m's macroglobulinemia: a study of 39 cases","volume":"20","author":"Terr\u00e9","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2013.02.015_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2013.02.015_bib8","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2006-02-005488","article-title":"Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma","volume":"108","author":"Chng","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2013.02.015_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.leu.2404520","article-title":"Gene expression profiling of B lymphocytes and plasma cells from Waldenstr\u00f6m's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals","volume":"21","author":"Guti\u00e9rrez","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2013.02.015_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clml.2013.02.015_bib11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.2011.213","article-title":"Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities","volume":"25","author":"Braggio","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clml.2013.02.015_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3324\/haematol.12221","article-title":"Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia","volume":"93","author":"Ferreira","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2013.02.015_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.clml.2013.02.015_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.2466","article-title":"A20 deletion is associated with copy number gain at the TNFA\/B\/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands","volume":"217","author":"Chanudet","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.clml.2013.02.015_bib15","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2013.02.015_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.clml.2013.02.015_bib17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.clml.2013.02.015_bib18","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clml.2013.02.015_bib19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clml.2013.02.015_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clml.2013.02.015_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/507687","article-title":"Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families","volume":"79","author":"McMaster","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clml.2013.02.015_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3324\/haematol.11052","article-title":"Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations","volume":"92","author":"Largo","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2013.02.015_bib23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/blood-2010-01-263806","article-title":"Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling","volume":"116","author":"Hartmann","year":"2010","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265013000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265013000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:24:24Z","timestamp":1761870264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265013000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S2152265013000207"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2013.02.015","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic Abnormalities of Waldenstr\u00f6m Macroglobulinemia and Related Low-Grade B-Cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2013.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}